
  Mrv0541 02231216452D          

  9  9  0  0  1  0            999 V2000
   -1.1908    1.7138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4763    2.1263    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.2382    1.7138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2382    0.8888    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6507    0.1743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1743    0.1743    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4763    2.9513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1908    3.3638    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2382    3.3638    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6  0  0  0
  2  3  1  0  0  0  0
  4  3  1  6  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  4  6  1  0  0  0  0
  2  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  2  0  0  0  0
M  END
> <DRUGBANK_ID>
DB03191

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
3-Oxiran-2ylalanine

> <CHEMICAL_FORMULA>
C5H9NO3

> <MOLECULAR_WEIGHT>
131.1299

> <EXACT_MASS>
131.058243159

> <IUPAC_NAME>
(2S)-2-amino-3-[(2R)-oxiran-2-yl]propanoic acid

> <IUPAC_TRADITIONAL_NAME>
3-oxiran-2ylalanine

> <INCHI_IDENTIFIER>
InChI=1S/C5H9NO3/c6-4(5(7)8)1-3-2-9-3/h3-4H,1-2,6H2,(H,7,8)/t3-,4+/m1/s1

> <INCHI_KEY>
InChIKey=HKPCHCJYQVJLIZ-DMTCNVIQSA-N

> <SMILES>
N[C@@H](C[C@@H]1CO1)C(O)=O

> <JCHEM_ACCEPTOR_COUNT>
4

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_ACIDIC_PKA>
2.08

> <JCHEM_BASIC_PKA>
9.45

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <ALOGPS_LOGP>
-2.9

> <JCHEM_LOGP>
-3.3

> <ALOGPS_LOGS>
0.54

> <JCHEM_POLARIZABILITY>
12.49

> <JCHEM_POLAR_SURFACE_AREA>
75.85

> <JCHEM_REFRACTIVITY>
29.36

> <JCHEM_ROTATABLE_BOND_COUNT>
3

> <ALOGPS_SOLUBILITY>
4.57e+02 g/l __ 

$$$$
